BioLargo, Inc. (BLGO)

OTCMKTS · Delayed Price · Currency is USD

0.1460

-0.0040 (-2.67%)

At close: Apr 21, 2026

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
ONM Environmental	5.91M	15.60M	11.44M	4.37M	1.42M
ONM Environmental Growth	-62.14%	36.34%	161.55%	208.25%	-9.50%
BLEST	2.55M	3.20M	2.40M	1.94M	1.64M
BLEST Growth	-20.39%	33.38%	23.37%	18.84%	55.71%
BioLargo Canada	86.00K	72.00K	30.00K	1,000.00	12.00K
BioLargo Canada Growth	19.44%	140.00%	2900.00%	-91.67%	-67.57%
Intersegment Revenue	-771.00K	-1.09M	-1.66M	-495.00K	-681.00K
BioLargo Corporate	-	-	-	5.00K	7.00K
BioLargo Corporate Growth	-	-	-	-28.57%	-50.00%
Clyra Medical	-	-	20.00K	56.00K	139.00K
Clyra Medical Growth	-	-	-64.29%	-59.71%	-42.08%
Total	7.77M	17.78M	12.23M	5.88M	2.53M
Total Growth	-56.32%	45.37%	107.85%	132.48%	4.07%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	7.77M	17.78M	12.23M	5.88M	2.53M
United States Growth	-56.32%	45.37%	107.85%	132.48%	4.07%
Total	7.77M	17.78M	12.23M	5.88M	2.53M
Total Growth	-56.32%	45.37%	107.85%	132.48%	4.07%

Source: S&P Global Market Intelligence.